Fabtech Technologies Cleanrooms Limited has announced that its board of directors, based on the recommendation of the Audit Committee, approved the incorporation of a wholly-owned subsidiary in the United Arab Emirates during their meeting held on December 17, 2025. This strategic decision aims to expand the company's manufacturing operations in the region under the UAE-India trade deal.

Board Meeting Details

The board meeting was held on Wednesday, December 17, 2025, where directors considered and approved the incorporation of the foreign wholly-owned subsidiary company. The decision was communicated to BSE Limited under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Subsidiary Incorporation Details

The proposed subsidiary will be incorporated under the name Fabtech Technologies Cleanrooms-FZE, subject to approval by UAE regulatory authorities.

Business Focus and Objectives

The subsidiary will focus on manufacturing partitions for supply to Fabtech Technologies Limited and Fabtech Technologies Cleanrooms Limited India. The initiative is designed to cater to Indian clients under the UAE-India trade deal, representing a shift from the previously announced pharmaceutical equipment focus to partition manufacturing.

The incorporation process is currently underway and will be completed subject to approvals from relevant authorities, including the Registrar of Companies in the UAE.

Strategic Implications

This expansion into the UAE market demonstrates Fabtech Technologies' commitment to leveraging international trade agreements to enhance its manufacturing capabilities. The subsidiary will enable the company to better serve its Indian client base while taking advantage of the UAE's strategic location and favorable trade conditions with India.

The incorporation is subject to approval from UAE regulatory authorities, and upon completion, the entity will become a wholly-owned subsidiary and related party of Fabtech Technologies Cleanrooms Limited.

Fabtech Technologies Cleanrooms Ltd. has reported a strong order inflow for October 2025, showcasing its growing presence in key industrial sectors. The company, which specializes in cleanroom and HVAC solutions, has secured consolidated orders worth ₹9.26 crore during the month, demonstrating its ability to capture opportunities across diverse industries.

Order Breakdown by Sector and Business Vertical

The order inflow reflects Fabtech's strong positioning in the pharmaceutical sector, which contributed the largest share at ₹6.55 crore. The data centre segment also showed significant traction with orders worth ₹2.68 crore.

Robust Order Book Position

As of October 31, 2025, Fabtech Technologies Cleanrooms Ltd. reported a consolidated order book of ₹165.16 crore, distributed across various sectors:

This diverse order book underscores the company's strategic focus on high-growth industries, particularly in renewable energy and pharmaceuticals.

Future Growth Prospects

Fabtech Technologies Cleanrooms Ltd. has indicated a strong pipeline of potential orders under active consideration, totaling ₹477.86 crore. The breakdown of these opportunities is as follows:

The substantial potential in renewable energy and semiconductors sectors signals the company's alignment with emerging industry trends and its capability to cater to advanced manufacturing facilities.

Fabtech Technologies Cleanrooms Ltd. continues to build momentum in the renewable energy and pharmaceutical sectors, reflecting its strategic diversification across high-growth industries. The company's ability to deliver integrated cleanroom and HVAC solutions positions it well to capitalize on the growing demand for advanced manufacturing facilities across various sectors.

Investors and market watchers may find Fabtech's order inflow and robust order book encouraging, as it indicates the company's potential for sustained growth in the coming quarters. However, it's important to note that the realization of potential orders and future performance will depend on various market factors and the company's execution capabilities.